- Home
- ASMB vs NMP Comparison
ASMB vs NMP Comparison
Compare ASMB & NMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- NMP
- Stock Information
- Founded
- ASMB 2005
- NMP 2024
- Country
- ASMB United States
- NMP United States
- Employees
- ASMB N/A
- NMP N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- NMP Blank Checks
- Sector
- ASMB Health Care
- NMP Finance
- Exchange
- ASMB Nasdaq
- NMP Nasdaq
- Market Cap
- ASMB 196.9M
- NMP 158.8M
- IPO Year
- ASMB 2010
- NMP 2025
- Fundamental
- Price
- ASMB $27.47
- NMP $9.97
- Analyst Decision
- ASMB Strong Buy
- NMP
- Analyst Count
- ASMB 4
- NMP 0
- Target Price
- ASMB $42.33
- NMP N/A
- AVG Volume (30 Days)
- ASMB 156.9K
- NMP 37.0K
- Earning Date
- ASMB 11-06-2025
- NMP 01-01-0001
- Dividend Yield
- ASMB N/A
- NMP N/A
- EPS Growth
- ASMB N/A
- NMP N/A
- EPS
- ASMB N/A
- NMP N/A
- Revenue
- ASMB $33,247,000.00
- NMP N/A
- Revenue This Year
- ASMB $14.32
- NMP N/A
- Revenue Next Year
- ASMB N/A
- NMP N/A
- P/E Ratio
- ASMB N/A
- NMP N/A
- Revenue Growth
- ASMB 54.77
- NMP N/A
- 52 Week Low
- ASMB $7.75
- NMP $9.90
- 52 Week High
- ASMB $27.90
- NMP $9.99
- Technical
- Relative Strength Index (RSI)
- ASMB 65.33
- NMP N/A
- Support Level
- ASMB $23.21
- NMP N/A
- Resistance Level
- ASMB $27.17
- NMP N/A
- Average True Range (ATR)
- ASMB 1.70
- NMP 0.00
- MACD
- ASMB 0.29
- NMP 0.00
- Stochastic Oscillator
- ASMB 97.82
- NMP 0.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About NMP NMP Acquisition Corp. Class A Ordinary Shares
NMP Acquisition Corp is a blank check company.